Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (2375)	3/22/2001 10:12:34 AM
From: Mark Bong	Respond to of 4974

Rick, PRCS now below 14. Prostrate drug before FDA and endometriosis drug met clinical endpoints in PII. What a pipeline and around $300MM in cash. They just raised $150Mm last week at around $23. Yea we are all hurting now, but these values can't last. I have some cash, but when this turns, margin can also be employed well. Things look like they will get worse before they get better though. CVTX and HGSI are great values here, but they may become a lot better before this is over.